Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 18.75 +0.055 (+0.29%) Market Cap: 59.89 Bil Enterprise Value: 88.63 Bil PE Ratio: 0 PB Ratio: 1.22 GF Score: 73/100

Takeda Pharmaceutical Co Ltd (TAK) Transcripts

  • 1